Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company manufactures agro-chemicals like herbicides, insecticides, fungicides, miticides, plant growth regulators
Dhanuka Laboratories Limited, was an unlisted public company incorporated on 24 February, 1993. It is classified as a public limited company and is located in Chennai, Tamil Nadu. It's authorized share capital was INR 14.50 cr and the total paid-up capital was INR 13.85 cr.
Read more
** All rupee values in INR crores.
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Rahul Dhanuka
Shareholder
|
00150140 | 28 years |
| Director | Mridul Dhanuka
Shareholder
|
00199441 | 21 years |
| Director | Harsh Dhanuka | 00199516 | 7 years |
| Managing Director | Manish Dhanuka
Shareholder
|
00238798 | 8 years |
| Director | Ram Gopal Agarwal | 00627386 | 7 years |
| Director | Arun Kumar Dhanuka | 00627425 | 34 years |
| Director | Mahendra Kumar Dhanuka
Shareholder
|
00628039 | 28 years |
| Director | Kunj Sonthalia | 00756382 | 7 years |
| Director | Sanjay Bagaria | 08280162 | 8 years |
| Director | Seema Dhanuka
Shareholder
|
00455088 | 30 years |
| Whole-time director | Arjun Dhanuka
Shareholder
|
00454689 | 6 years |
| Director | Urmila Dhanuka | 01252045 | 25 years |
| Director | Shweta Bansal | 08396474 | 1 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2025 available in Tofler Pro
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| ORCHID PHARMA LIMITED | Tamil Nadu | 1992 | ₹ 50.7 Cr |
| ORCHID BIO-PHARMA LIMITED | Tamil Nadu | 2022 | ₹ 15.0 Cr |
| Orchid Pharmaceuticals Inc., and Subsidiaries, USA | United States | - | - |
| BexelPharmaceuticals Inc., USA | United States | - | - |
| DiakronPharmaceuticals Inc, USA | United States | - | - |
Read more
The incorporation date of DHANUKA LABORATORIES LIMITED is 24 February, 1993
The authorized share capital of DHANUKA LABORATORIES LIMITED is INR ₹ 14.5 Cr.
The paid-up capital of DHANUKA LABORATORIES LIMITED is INR ₹ 13.8 Cr.
The registered address of DHANUKA LABORATORIES LIMITED is LINBUZZ BUSINESS CENTRE, 2910B 14TH MAIN ROAD ANNA NAGAR WEST CHENNAI Tamil Nadu - 600040
The CIN number of DHANUKA LABORATORIES LIMITED is U24100TN1993PLC149053.